Literature DB >> 30363698

Resection for Klatskin tumors: technical complexities and results.

Ivan Capobianco1, Jens Rolinger1, Silvio Nadalin1.   

Abstract

Klatskin's tumors, actually-redefined as perihilar cholangiocarcinoma (phCCA) do represent 50-70% of all CCAs and develop in a context of chronic inflammation and cholestasis of bile ducts. Surgical resection provides the only chance of cure for this disease but is technically challenging because of the complex, intimate and variable relationship between biliary and vascular structures at this location. Five years survival rates range between 25-45% (median 27-58 months) in case of R0 resection and 0-23% (median 12-21 months) in case of R1 resection respectively. It should be noted that the major costs of high radicality are represented by relative high morbidity and mortality rates (i.e., 20-66% and 0-9% respectively). Considering the fact that radical resection may represent the only curative treatment of phCCA, we focused our review on surgical planning and techniques that may improve resectability rates and outcomes for locally advanced phCCA. The surgical treatment of phCCA can be successful when following aspects have been fulfilled: (I) accurate preoperative diagnostic aimed to identify the tumor in all its details (localization and extension) and to study all the risk factors influencing a posthepatectomy liver failure (PHLF): i.e., liver volume, liver function, liver quality, haemodynamics and patient characteristics; (II) High end surgical skills taking in consideration the local extension of the tumor and the vascular invasion which usually require an extended hepatic resection and often a vascular resection; (III) adequate postoperative management aimed to avoid major complications (i.e., PHLF and biliary complications). These are technically challenging operations and must be performed in a high volume centres by hepato-biliary-pancreas (HBP)-surgeons with experience in microsurgical vascular techniques.

Entities:  

Keywords:  Klatskin; Perihilar cholangiocarcinoma; surgery

Year:  2018        PMID: 30363698      PMCID: PMC6182019          DOI: 10.21037/tgh.2018.09.01

Source DB:  PubMed          Journal:  Transl Gastroenterol Hepatol        ISSN: 2415-1289


  261 in total

1.  The use of indocyanine green in the measurement of hepatic blood flow and as a test of hepatic function.

Authors:  J CAESAR; S SHALDON; L CHIANDUSSI; L GUEVARA; S SHERLOCK
Journal:  Clin Sci       Date:  1961-08       Impact factor: 6.124

2.  Reappraisal of hepatopancreatoduodenectomy as a treatment modality for bile duct and gallbladder cancer.

Authors:  Chang-Sup Lim; Jin-Young Jang; Seung Eun Lee; Mee Joo Kang; Sun-Whe Kim
Journal:  J Gastrointest Surg       Date:  2012-01-24       Impact factor: 3.452

3.  Efficacy of Preoperative Portal Vein Embolization Among Patients with Hepatocellular Carcinoma, Biliary Tract Cancer, and Colorectal Liver Metastases: A Comparative Study Based on Single-Center Experience of 319 Cases.

Authors:  Suguru Yamashita; Yoshihiro Sakamoto; Satoshi Yamamoto; Nobuyuki Takemura; Kiyohiko Omichi; Hiroji Shinkawa; Kazuhiro Mori; Junichi Kaneko; Nobuhisa Akamatsu; Junichi Arita; Kiyoshi Hasegawa; Norihiro Kokudo
Journal:  Ann Surg Oncol       Date:  2017-02-10       Impact factor: 5.344

4.  High mortality after ALPPS for perihilar cholangiocarcinoma: case-control analysis including the first series from the international ALPPS registry.

Authors:  Pim B Olthof; Robert J S Coelen; Jimme K Wiggers; Bas Groot Koerkamp; Massimo Malago; Roberto Hernandez-Alejandro; Stefan A Topp; Marco Vivarelli; Luca A Aldrighetti; Ricardo Robles Campos; Karl J Oldhafer; William R Jarnagin; Thomas M van Gulik
Journal:  HPB (Oxford)       Date:  2017-03-06       Impact factor: 3.647

5.  Is extended hemihepatectomy plus pancreaticoduodenectomy justified for advanced bile duct cancer and gallbladder cancer?

Authors:  Yoshihiro Sakamoto; Satoshi Nara; Yoji Kishi; Minoru Esaki; Kazuaki Shimada; Norihiro Kokudo; Tomoo Kosuge
Journal:  Surgery       Date:  2013-02-13       Impact factor: 3.982

Review 6.  The model for end-stage liver disease (MELD).

Authors:  Patrick S Kamath; W Ray Kim
Journal:  Hepatology       Date:  2007-03       Impact factor: 17.425

Review 7.  Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases.

Authors:  D Zorzi; A Laurent; T M Pawlik; G Y Lauwers; J-N Vauthey; E K Abdalla
Journal:  Br J Surg       Date:  2007-03       Impact factor: 6.939

8.  Preoperative assessment of liver function: a comparison of 99mTc-Mebrofenin scintigraphy with indocyanine green clearance test.

Authors:  Deha Erdogan; Bob H M Heijnen; Roelof J Bennink; Mariël Kok; Sander Dinant; Irene H Straatsburg; Dirk J Gouma; Thomas M van Gulik
Journal:  Liver Int       Date:  2004-04       Impact factor: 5.828

9.  Hospital mortality of major hepatectomy for hepatocellular carcinoma associated with cirrhosis.

Authors:  S T Fan; E C Lai; C M Lo; I O Ng; J Wong
Journal:  Arch Surg       Date:  1995-02

Review 10.  Cancer review: Cholangiocarcinoma.

Authors:  Yezaz Ahmed Ghouri; Idrees Mian; Boris Blechacz
Journal:  J Carcinog       Date:  2015-02-23
View more
  5 in total

1.  Liver resection for extra-pancreatic biliary cancer: what is the role of laparoscopic approach?

Authors:  Walid Elmoghazy; Jane Cowan; Nicolas Tabchouri; Pascale Tinguely; Mostefa Bennamoun; Candice Tubbax; Anthony Sarran; Marine Lefevre; Christian Lamer; Brice Gayet; David Fuks
Journal:  Surg Endosc       Date:  2019-01-28       Impact factor: 4.584

2.  Central hepatopancreatoduodenectomy-oncological effectiveness and parenchymal sparing option for diffusely spreading bile duct cancer: report of two cases.

Authors:  Kapil Nagaraj; Yuichi Goto; Satoki Kojima; Hisamune Sakai; Toru Hisaka; Yoshito Akagi; Koji Okuda
Journal:  BMC Surg       Date:  2021-01-06       Impact factor: 2.102

3.  The Prevalence and Clinical Significance of Anaerobic Bacteria in Major Liver Resection.

Authors:  Jens Strohäker; Sophia Bareiß; Silvio Nadalin; Alfred Königsrainer; Ruth Ladurner; Anke Meier
Journal:  Antibiotics (Basel)       Date:  2021-01-31

4.  Cumulative damage effect of jaundice may be an effective predictor of complications in patients undergoing radical resection of Bismuth type II or above hilar cholangiocarcinoma.

Authors:  Le Luo; Yutong Yao; Haotian Liao; Jiwei Huang; Mingheng Liao; Jinju Wang; Kefei Yuan; Yong Zeng
Journal:  Ann Transl Med       Date:  2021-05

5.  Alveolar Echinococcosis-A Challenging Task for the Hepatobiliary Surgeon.

Authors:  Jens Strohaeker; Mihaly Sulyok; Alfred Koenigsrainer; Silvio Nadalin
Journal:  Pathogens       Date:  2021-12-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.